BIOTECHNOLOGY VALUE FUND L P - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Cidara Therapeutics, Inc. (CDTX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CDTX
Shares outstanding
10.9M shares
Disclosed Ownership
1.09M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:05 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 4.5% 495K 0 495K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 4.5% 495K 0 495K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.5% 489K 0 489K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.5% 489K 0 489K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.6% 63.5K 0 63.5K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.6% 63.5K 0 63.5K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9% 984K 0 984K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 1.09M 0 1.09M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 1.09M 0 1.09M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 1.09M 0 1.09M /s/ Mark N. Lampert Mark N. Lampert